David Bench, Chief Financial Officer at ENZO BIOCHEM INC (ENZ), bought 3,500 shares at $2.15 ($8K) on 2022-06-14, disclosed to the SEC on 2022-06-15.
Open-market purchase of $8k ENZ by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.